换一批
换一批Towards effective immunotherapy of myeloma: enhanced elimination of myeloma cells by combination of lenalidomide with the human CD38 monoclonal antibody daratumumab.
第一作者：
Michael S,van der Veer
第一单位：
Dept. of Clinical Chemistry and Hematology, University Medical Center Utrecht, Utrecht, The Netherlands.
作者：
主题词
抗体, 单克隆(Antibodies, Monoclonal);抗体依赖细胞细胞毒性(Antibody-Dependent Cell Cytotoxicity);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);骨髓(Bone Marrow);补体系统蛋白质类(Complement System Proteins);细胞毒性, 免疫(Cytotoxicity, Immunologic);人类(Humans);免疫表型分型(Immunophenotyping);免疫疗法(Immunotherapy);多发性骨髓瘤(Multiple Myeloma);沙立度胺(Thalidomide);肿瘤细胞, 培养的(Tumor Cells, Cultured)
DOI
10.3324/haematol.2010.030759
PMID
21109694
发布时间
2021-10-20
- 浏览8
Haematologica
284-90页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
